LEADER 03318nam 2200757 450 001 9910137204903321 005 20230621141305.0 035 $a(CKB)3710000000520138 035 $a(SSID)ssj0001683370 035 $a(PQKBManifestationID)16509392 035 $a(PQKBTitleCode)TC0001683370 035 $a(PQKBWorkID)15037796 035 $a(PQKB)11763471 035 $a(WaSeSS)IndRDA00056673 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/54523 035 $a(EXLCZ)993710000000520138 100 $a20160829d2014 fy 0 101 0 $aeng 135 $aur||#---||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aNeuropeptide GPCRs in neuroendocrinology /$ftopic editors Hubert Vaudry and Jae Young Seong 210 $cFrontiers Media SA$d2014 210 1$a[Lausanne, Switzerland] :$cFrontiers Media SA,$d2014. 215 $a1 online resource (825 pages) $cillustrations; digital file(s) 225 1 $aFrontiers Research Topics 225 1 $aFrontiers in Endocrinology 225 1 $aFrontiers in Neuroscience 300 $aBibliographic Level Mode of Issuance: Monograph 311 $a2-88919-267-9 320 $aIncludes bibliographical references. 330 3 $aThe human genome encompasses ? 860 G protein-coupled receptors (GPCRs) including 374 non-chemosensory GPCRs. Half of these latter GPCRs recognize (neuro)peptides as natural ligands. GPCRs thus play a pivotal role in neuroendocrine communication. In particular, GPCRs are involved in the neuroendocrine control of feeding behavior, reproduction, growth, hydromineral homeostasis and stress response. GPCRs are also major drug targets and hence possess a strong potential for the development of innovative pharmaceuticals. The aim of this Research Topic is to assemble a series of review articles and original research papers on neuropeptide GPCRs and their ligands that will illustrate the different facets of the studies currently conducted in this domain. 410 0$aFrontiers research topics. 410 0$aFrontiers in endocrinology. 410 0$aFrontiers in neuroscience. 517 1 $aNeuropeptide G protein-coupled receptors in neuroendocrinology 606 $aNeuroendocrinology 606 $aNeuropharmacology 606 $aEndocrinology 606 $aAnimal Biochemistry$2HILCC 606 $aHuman Anatomy & Physiology$2HILCC 606 $aHealth & Biological Sciences$2HILCC 610 $aTransduction pathways 610 $aG protein-coupled receptors 610 $aNeuroendocrinology 610 $aHeptahelical receptors 610 $aNeuropeptides 610 $aSignaling mechanisms 610 $aBiologically active peptides 610 $aseven-transmembrane domain receptors 615 0$aNeuroendocrinology. 615 0$aNeuropharmacology. 615 0$aEndocrinology. 615 7$aAnimal Biochemistry 615 7$aHuman Anatomy & Physiology 615 7$aHealth & Biological Sciences 700 $aJae Young Seong$4auth$01364364 702 $aVaudry$b Hubert 702 $aSeong$b Jae Young 801 0$bPQKB 801 2$bUkMaJRU 906 $aBOOK 912 $a9910137204903321 996 $aNeuropeptide GPCRs in neuroendocrinology$93385571 997 $aUNINA LEADER 01174nam2-2200385---450- 001 990003558210203316 005 20110901095011.0 010 $a0-905205-92-8 035 $a000355821 035 $aUSA01000355821 035 $a(ALEPH)000355821USA01 035 $a000355821 100 $a20110830d1998----km-y0itay50------ba 101 0 $alat 101 0 $aeng 102 $aGB 105 $a||||||||001yy 200 1 $a<<3:>> <> commentary on Book two$etext, prolegomena and commentary$ein four volumes$f[edited by] J. C. McKeown 210 $aLiverpool [poi] Leeds$cF. Cairns$d1998 215 $aXXXIII, 433 p.$d22 cm 225 2 $aArca$v36 410 0$12001$aArca$v36 461 0$1001000355820$12001$aOvid: Amores 700 1$aMCKEOWN,$bJ. C.$011900 702 1$aOVIDIUS NASO,$bPublius 801 0$aIT$bsalbc$gISBD 912 $a990003558210203316 951 $aV.3.B. 433 3$b232927 L.M.$cV.3.B.$d00298653 959 $aBK 969 $aUMA 979 $aIANNONE$b90$c20110830$lUSA01$h1321 979 $aIANNONE$b90$c20110901$lUSA01$h0928 979 $aIANNONE$b90$c20110901$lUSA01$h0950 996 $aCommentary on Book two$91117380 997 $aUNISA